_content="""# TISSUE LAYER INDUSTRIALIZATION MODEL

---

## SECTION I — PURPOSE

This document is the constitutional authority governing the industrialized execution of the Tissue Layer (Layer 3). No Tissue industrialization may commence before the Cell Layer (Layer 2) is 100% ratified. All Tissues must comply with the invariants of their constituent Cells and Organelles, and no Tissue may redefine the semantics of these lower layers.

---

## SECTION II — TISSUE DEFINITION

A Tissue is a coordination structure that orchestrates multiple ratified Cells into a cohesive functional grouping without introducing domain semantics.

- A Tissue **MUST** be composed only of ratified Cells.
- A Tissue **MUST NOT** embed business semantics, which belong to the Organ Layer (Layer 4).
- A Tissue **MUST NOT** embed UI logic.
- A Tissue **MUST NOT** define deployment topology.
- A Tissue **MUST NOT** bypass the Cell abstraction to interact directly with Organelles.

---

## SECTION III — INDUSTRIALIZATION GATING RULE

Tissue bulk generation is permitted only when the following conditions are met:

- The Cell Layer is 100% ratified.
- There are no frozen entries in the Cell Layer.
- The global drift scan is clean.
- Founder authorization has been granted.

Partial unlocking of the Tissue Layer is not permitted.

---

## SECTION IV — TISSUE TASK HIERARCHY MODEL

The task hierarchy for a Tissue is a strict three-level model:

1.  **Level 1:** Tissue Master Issue
2.  **Level 2:** 7 Phase Issues (0–6)
3.  **Level 3:** Atomic Task Units

A minimum of 21 atomic tasks (3 per phase) is required for each Tissue. No fourth level is permitted.

---

## SECTION V — TISSUE NUMBERING MODEL

The standardized identifier format for a Tissue is:
`TIS-<DOMAINCODE>-<TISSUENAME>-v<Version>`

- **Master Issue Format:** `[TissueID] Master Issue`
- **Phase Issue Format:** `[TissueID-P#] Phase Name`
- **Atomic Task Format:** `[TissueID-P#-T##] Task Name`
- **Version Inheritance Rule:** A Tissue

's version must inherit from the versions of its constituent Cells.

---

## SECTION VI — CELL-TO-TISSUE DEPENDENCY MODEL

- All Cells composing a Tissue must be at least **Phase 4 (Verified)** before the Tissue's Phase 3 (Implementation) can begin.
- No Tissue may depend on an unverified Cell.
- Dependency declaration is mandatory in the Tissue Master Issue.
- No upward dependencies are permitted.

---

## SECTION VII — PHASE SYNCHRONIZATION FLOOR

A cross-layer phase synchronization floor is enforced to maintain stability:

- **Synchronization Floor:** Tissue Phase `N` may only begin when all composing Cells are at or beyond Phase `N+1`.
- **Dependency Verification:** This dependency must be verified before phase transition.
- **Lock Rule:** A Tissue is locked if any of its dependent Cells are frozen or blocked.

---

## SECTION VIII — PARALLELIZATION RULES

- **Allowed:** Multiple Tissues may be in Phase 0 or Phase 1 simultaneously.
- **Not Allowed:** A Tissue cannot enter Phase 3 if its Cell dependencies are not met. Parallel implementation of Tissues sharing the same Cells is not allowed unless explicitly declared and approved.

---

## SECTION IX — DRIFT PREVENTION

The following are specific freeze triggers for the Tissue Layer:

- **Cross-Cell Semantic Mutation:** A Tissue altering the intended meaning of a constituent Cell.
- **Introduction of Business Logic:** A Tissue containing domain-specific business logic.
- **Primitive Leakage Upward:** A Tissue exposing the primitive functions of its Cells directly to the Organ Layer.
- **Downward Mutation Attempt:** A Tissue attempting to alter the behavior of a constituent Cell.
- **Abstraction Bypass:** A Tissue bypassing the Cell abstraction to interact directly with Organelles.

---

## SECTION X — WAVE EXPANSION MODEL

The Tissue Layer will also follow a wave-based industrialization model:

- Wave 1 Tissues
- Wave 2 Tissues
- Wave 3 Tissues

No wave activation is permitted without Founder authorization.

---

## SECTION XI — GLOBAL TRACKER INTEGRATION

Additional tracking requirements for the Tissue Layer include:

- Parent Cells declared
- Downstream Organ candidates declared
- Synchronization phase recorded
- Structural risk score calculated

---

## SECTION XII — RATIFICATION STATEMENT

| | |
|---|---|
| **Status** | RATIFIED |
| **Authority** | Founder |
| **Date** | 2026-02-19 |

This document is constitutionally binding.

---

## SECTION XIII — PRIMITIVE INTEGRATION DISCIPLINE COMPLIANCE

All Tissues must comply with the primitive integration discipline defined in `ORGANELLE_CATEGORY_DEPENDENCY_GLOBAL_MAP.md`. This includes the mandatory use of CI, EI, and IN categories for their designated purposes. Domain Activation Token issuance requires full integration coverage completeness, and Pre-Generation completeness includes the presence of CI, EI, and IN archetypes.
